Ipratropium bromide
Yi palo
| Names | |
|---|---|
| Trade names | Atrovent, Apovent, Ipraxa, others |
| |
| Clinical data | |
| Main uses | COPD, asthma[1] |
| WHO AWaRe | Script error: No such module "WDfetch". |
| Pregnancy category | Tɛmplet:Infobox drug/pregnancy category |
| Routes of use | Inhalation, nasal |
| Onset of action | 15 to 30 min[1] |
| Duration of action | 3 to 5 hours[1] |
| Defined daily dose | 0.12 to 0.3 mg[2] |
| External links | |
| AHFS/Drugs.com | Inhaled: Tɛmplet:Drugs.com Nose: Tɛmplet:Drugs.com |
| MedlinePlus | a618013 |
| Legal | |
| [[Regulation of therapeutic goods |Tɛmplet:Engvar data]] | Tɛmplet:Infobox drug/licence |
| Legal status | Tɛmplet:Infobox drug/legal status |
| Pharmacokinetics | |
| Protein binding | 0 to 9% in vitro |
| Metabolism | Liver |
| Elimination half-life | 2 hours |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| PubChem SID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| NIAID ChemDB | |
| PDB ligand | |
| CompTox Dashboard (EPA) | |
| ATC code | |
| Chemical and physical data | |
| Formula | Tɛmplet:Infobox drug/chemical formula |
| Molar mass | Tɛmplet:Chem molar mass |
| 3D model (JSmol) | |
| |
| |
Tɛmplet:Infobox drug/maintenance categories
Ipratropium bromide, Tila'shɛli bɛ ni lahi booni Atrovent la nyɛla ti' shɛli di yoori sapuɣi pɔhim soya[3] Di nyɛla ti' laa shɛli din tibiri doriti kamani chronic obstructive pulmonary disease nti pahi asthma ningbuŋ nahingbana[3] Di ŋmahin di mi n niŋ nyahini bee sapuhi ni [3] Di tuma pilibu ningbuŋ puuni diri la kamani minti pia ni anu hali ni minti pihita ka ni tooi na mali yaa ha li ni awa diba ata n ti kpa awa di ba anu zuɣu [3]
References
[mali niŋ | mali mi di yibu sheena n-niŋ]- 1 2 3 Ipratropium Bromide. The American Society of Health-System Pharmacists.
- ↑ WHOCC - ATC/DDD Index.
- 1 2 3 4 Ipratropium Bromide. The American Society of Health-System Pharmacists.